Provectus Biopharmaceuticals, Inc. announced additions to its executive leadership team, reflecting Provectus's dedication to enhancing shareholder value. The Company?s Board of Directors (the ?Board?) has appointed Ed Pershing as Chief Executive Officer (?CEO?) and Dominic Rodrigues as President. Mr. Rodrigues worked in management consulting and corporate development in science and technology-driven industries prior to Provectus.

He also was a finance professor at the University of Nevada, Las Vegas, a venture capitalist at defense contractor SAIC, a currency derivatives trader at Bank of Montreal, and a project manager and engineer at Jacques Whitford. Mr. Rodrigues holds business, economics, engineering, and public policy degrees from The Wharton School, the London School of Economics, MIT, and the University of Toronto.